Alternatively, TGF-β plays a dual role in prostate cancer; in the initial stages, it acts as an anti-proliferative factor, while in the advanced stages, it acquires pro-metastatic and pro-oncogenic qualities [70]. This evidence concerns the gene TGFB1 and prostate carcinoma.